Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Amorphous letermovir and solid pharmaceutical formulations thereof for oral administration

Amorphous letermovir and solid pharmaceutical formulations thereof for oral administration

US Patent 10442773 · Granted Oct 15, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trif2025
N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phen2024
Treatment of cardiopulmonary disorders2024
Sulfate salt of the free base of n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]2024
Salts of a dihydroquinazoline derivative2024
Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyr2023
Method for the hydrolysis of quinolonecarboxylic esters2022
Maleate salt of the free base of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]2022
N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phen2021
Pharmaceutical composition containing an antivirally active dihydroquinazoline d2020
Bendamustine derivatives and related compounds, and medical use thereof in cance2020
Bendamustine derivatives and related compounds, and medical use thereof in cance2020